Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa vs Pamidronate for bone metastasis pain
NCT00219258Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in bone metastasis, multiple myeloma (MM), sponsored by Novartis. Started Jul 2005; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastasismultiple myeloma (MM)
Beyond the preview
Go deeper on NCT00219258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219258.